GlassScriptPhysician profile
Terrence J Roberts
NPI 1194157289
$552.58
in general payments reported to CMS, 2019-2025
8 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.61 · 2020: $17.78 · 2021: $34.98 · 2022: $73.24 · 2023: $116 · 2024: $67.79 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297 · Entertainment: $51.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.06 |
| Entertainment | $51.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $189.36 | 2021-2023 | Acuvue |
| Bausch & Lomb Americas INC. | $147.87 | 2023-2025 | Infuse, Miebo, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $55.61 | 2019-2021 | |
| Optos, INC. | $51.91 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Genzyme Corporation | $50.00 | 2025 | |
| Carl Zeiss Meditec, INC. | $28.09 | 2019 | |
| Coopervision INC. | $17.78 | 2020 | |
| Shire North American Group INC | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terrence Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.